These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20495135)

  • 41. Limited sampling models for doxorubicin pharmacokinetics.
    Ratain MJ; Robert J; van der Vijgh WJ
    J Clin Oncol; 1991 May; 9(5):871-6. PubMed ID: 2016631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs.
    Janssen JM; Dorlo TPC; Beijnen JH; Huitema ADR
    Ther Drug Monit; 2020 Aug; 42(4):532-539. PubMed ID: 32384536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of three a priori methods and one empirical method in predicting lithium dosage requirements.
    Wright R; Crismon ML
    Am J Health Syst Pharm; 2000 Sep; 57(18):1698-702. PubMed ID: 11006797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data.
    Le Louedec F; Gallais F; Thomas F; White-Koning M; Allal B; Protin C; Ysebaert L; Chatelut É; Puisset F
    Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33670575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simplified account of drug accumulation and steady-state dose equivalences.
    Swartz CM
    J Clin Pharmacol; 1997 Oct; 37(10):962-70. PubMed ID: 9505988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What the clinician still has to be reminded of.
    Zernig G; Lechner T; Kramer-Reinstadler K; Hinterhuber H; Hiemke C; Saria A
    Ther Drug Monit; 2004 Oct; 26(5):582. PubMed ID: 15385844
    [No Abstract]   [Full Text] [Related]  

  • 47. Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults.
    Liyanage M; Blaquera CL; Piscitelli J; Penzak SR; Nolin TD; Paine MF; Ma JD
    Int J Clin Pharmacol Ther; 2023 Jun; 61(6):262-269. PubMed ID: 37042268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach.
    Piscitelli J; Nikanjam M; Capparelli EV; Blaquera CL; Penzak SR; Nolin TD; Paine MF; Ma JD
    Ther Drug Monit; 2023 Aug; 45(4):539-545. PubMed ID: 36645711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties.
    Bonnet U
    CNS Drug Rev; 2002; 8(3):283-308. PubMed ID: 12353059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetics and metabolism of reversible MAO-A inhibitors in the human].
    Schoerlin MP; Guentert TW
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():11-7. PubMed ID: 2685852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of single-point sampling strategies for the estimation of moclobemide exposure in depressive patients.
    Ignjatovic AR; Miljkovic B; Todorovic D; Timotijevic I; Pokrajac M
    J Clin Pharmacol; 2011 May; 51(5):661-71. PubMed ID: 20495135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limited-sampling strategy for the prediction of boosted hard-gel saquinavir exposure at a dosage of 1000/100 mg twice daily in human immunodeficiency virus-infected individuals.
    Dickinson L; Back D; Pozniak A; Khoo S; Boffito M
    Ther Drug Monit; 2007 Jun; 29(3):361-7. PubMed ID: 17529895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
    König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
    Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.
    Ragette R; Kamler M; Weinreich G; Teschler H; Jakob H
    J Heart Lung Transplant; 2005 Sep; 24(9):1315-9. PubMed ID: 16143250
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.